Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Health

Canberra woman's overdose marks ACT's first death linked to potent synthetic opioid

A 42-year-old woman in Canberra died in July 2022 after an overdose involving protonitazene, a synthetic opioid estimated to be at least 100 times stronger than heroin.

In July 2022, a 42-year-old woman was found dead in her Ainslie home in Canberra after her housemate called emergency services. A post-mortem identified a mixture of substances in her blood, most notably protonitazene, a new psychoactive synthetic opioid believed to be at least 100 times more potent than heroin. The ACT Coroner's Court, presided over by Ken Archer, ruled the death the first in the ACT linked to such a substance, attributing it to multiple drug toxicity with vomit aspiration as a contributing factor.

Police recovered drug-related paraphernalia, including uncapped syringes, naloxone nasal spray, fentanyl test strips, and several prescription medications, and later discovered her name in a notebook tied to a broader synthetic opioid distribution network. While the forensic pathologist could not determine if protonitazene alone caused the death, the coroner highlighted the growing national trend of deaths involving novel substances and the need for faster toxicology capabilities and coordinated public alerts.

Why it matters

The case highlights rising risks from ultra-potent synthetic opioids and gaps in rapid public health warnings.

In this story

protonitazenesynthetic opioidoverdose deathnovel psychoactive substancetoxicologydrug checkingheroinpublic health warningACT coroner
Get the beta ↗